What is Aurinia Pharmaceuticals's price / earnings?

Aurinia Pharmaceuticals (AUPH) reported price / earnings of 6.6× in Q1 2026.

How has Aurinia Pharmaceuticals's price / earnings changed year-over-year?

Aurinia Pharmaceuticals's price / earnings decreased by 76.2% year-over-year, from 27.7× to 6.6×.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Aurinia Pharmaceuticals AUPH Price / earnings

Price / earnings at other companies

Rogers CorporationROG

71.9×+39.4×

ANI PharmaceuticalsANIP

18.7×—

Agios PharmaceuticalsAGIO

3.7×—

Kiniksa Pharmaceuticals International, plcKNSA

50.4×—

Arrowhead ResearchARWR

44.6×—

ALN

Alnylam PharmaceuticalsALNY

87.4×—

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/S7.7×+2.5×

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Calculated from Aurinia Pharmaceuticals’s reported figures.

market cap/net income=6.6×

Based on the most recent quarter.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's price / earnings?: Aurinia Pharmaceuticals (AUPH) reported price / earnings of 6.6× in Q1 2026.
How has Aurinia Pharmaceuticals's price / earnings changed year-over-year?: Aurinia Pharmaceuticals's price / earnings decreased by 76.2% year-over-year, from 27.7× to 6.6×.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.